Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Compound 15a was effective in inhibiting 5α-reductase.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Polycomb Repressive Complex 2 is not needed for hair regeneration.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Minoxidil increases nail growth more than biotin.

The research helps understand how finasteride works and aids drug development.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

ESR2 gene linked to female-pattern hair loss.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

COVID-19 may cause early hair loss by infecting hair follicles.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.